FATE insider trading — Fate Therapeutics Inc
Over the last 90 days, insiders at Fate Therapeutics Inc (FATE) made 0 open-market purchases worth $0 and 2 open-market sales worth $204K, making them net sellers by $204K. The largest sale was by Valamehr Bahram (President and CEO), who sold 43,947 shares for $108K on Aug 4, 2026.
Updated Oct 16, 2026.
Recent FATE insider transactions
Every Form 4 filed by Fate Therapeutics Inc officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Tahl Cindy | See Remarks | S · Sale | Direct | 38,800 | $2.46 | $95K | Form 4 |
| Aug 4, 2026 | Valamehr Bahram | President and CEO | S · Sale | Direct | 43,947 | $2.46 | $108K | Form 4 |
FATE insider trading FAQ
Are insiders buying FATE stock?
Not on the open market. In the last 90 days, Fate Therapeutics Inc insiders made no open-market purchases, and 2 open-market sales totaling $204K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading FATE?
Recent sellers: Tahl Cindy, Valamehr Bahram.
Where does FATE insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.